Phibro Animal Health Corporation

PAHC.US
Healthcare · Drug Manufacturers - Specialty & Generic
36.37
+1.13 (+3.21%)
USD · NASDAQ

Company Information

Company Name
Phibro Animal Health Corporation
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
ISIN: US71742Q1067
CIK: 0001069899
CUSIP: 71742Q106
Currency: USD
Full Time Employees: 2,475
Phone: 201 329 7300
Fiscal Year End: June
IPO Date: Apr 11, 2014
Description:

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in developing, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, copper, manganese, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for use in personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 1946 and is headquartered in Teaneck, New Jersey.

Address:

Glenpointe Centre East, Teaneck, NJ, United States, 07666-6712

People

Directors & Officers

Name Title Year Born
Mr. Jack Clifford Bendheim Executive Chairman 1947
Mr. Daniel M. Bendheim J.D. CEO, President & Director 1972
Mr. Glenn C. David Chief Financial Officer 1972
Mr. Larry L. Miller Chief Operating Officer 1964
Ms. Judith A. Weinstein Senior VP, General Counsel & Corporate Secretary 1969
Mr. Jonathan Bendheim Executive Vice President of Global Technology & People and Director 1977
Ms. Lisa A. Escudero Senior Vice President of Human Resources 1962
Mr. Ramon Fuenmayor President South America Region NA
Mr. Samson Li President of Asia Pacific Region 1972
Mr. Todd Armstrong President of North American Region NA

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Apr 22, 2026 Jack Bendheim N/A Sale 7.04K $54.29 $382.20K
Apr 16, 2026 Jack Bendheim N/A Sale 7.04K $54.64 $384.67K
Apr 14, 2026 Jack Bendheim N/A Sale 7.04K $59.08 $415.92K
Mar 19, 2026 Jack Bendheim N/A Sale 7.04K $52.52 $369.74K
Mar 18, 2026 Jack Bendheim N/A Sale 10.56K $52.68 $556.30K
Mar 17, 2026 Jack Bendheim N/A Sale 5.28K $51.66 $272.76K
Mar 13, 2026 Jack Bendheim N/A Sale 5.28K $48.91 $258.24K
Feb 26, 2026 Jack Bendheim N/A Sale 7.04K $53.73 $378.26K
Feb 24, 2026 Jack Bendheim N/A Sale 7.04K $51.37 $361.64K
Feb 20, 2026 Jack Bendheim N/A Sale 7.04K $51.42 $362.00K
Feb 18, 2026 Jack Bendheim N/A Sale 7.04K $51.40 $361.86K
Feb 13, 2026 Jack Bendheim N/A Sale 7.04K $51.96 $365.80K
Feb 11, 2026 Jack Bendheim N/A Sale 14.18K $51.62 $732.18K
Feb 10, 2026 Jack Bendheim N/A Sale 58.01K $51.81 $3.01M
Feb 05, 2026 Jack Bendheim N/A Sale 110.84K $48.38 $5.36M
Feb 04, 2026 Jack Bendheim N/A Sale 3.52K $41.15 $144.85K
Feb 03, 2026 Jack Bendheim N/A Sale 9.66K $41.47 $400.60K
Jan 30, 2026 Jack Bendheim N/A Sale 6.69K $40.09 $268.32K
Jan 29, 2026 Jack Bendheim N/A Sale 6.77K $40.12 $271.69K
Jan 23, 2026 Jack Bendheim N/A Sale 1.24K $40.55 $50.08K

Shareholders

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
BlackRock Inc 3.25M Mar 31, 2026 8.02% $0.00 -2.74%
FMR Inc 2.17M Mar 31, 2026 5.36% $0.01 215.58%
Vanguard Group Inc 1.54M Dec 31, 2025 3.80% $0.00 0.91%
State Street Corp 950.03K Mar 31, 2026 2.34% $0.00 0.82%
Vanguard Capital Management, LLC 891.28K Mar 31, 2026 2.20% $0.00 0.00%
Acadian Asset Management LLC 617.07K Mar 31, 2026 1.52% $0.05 243.72%
Geode Capital Management, LLC 604.65K Mar 31, 2026 1.49% $0.00 6.24%
Renaissance Technologies Corp 576.74K Mar 31, 2026 1.42% $0.05 5.76%
Dimensional Fund Advisors, Inc. 507.85K Mar 31, 2026 1.25% $0.01 3.15%
Vanguard Portfolio Management, LLC 490.34K Mar 31, 2026 1.21% $0.00 0.00%
Nuveen, LLC 455.89K Mar 31, 2026 1.12% $0.01 2.62%
Lord, Abbett & Co LLC 397.71K Mar 31, 2026 0.98% $0.07 181.65%
Morgan Stanley - Brokerage Accounts 391.19K Mar 31, 2026 0.96% $0.00 -12.55%
Amvescap Plc. 330.98K Mar 31, 2026 0.82% $0.00 28.16%
Dana Investment Advisors Inc 287.72K Mar 31, 2026 0.71% $0.47 -12.46%
Allspring Global Investments Holdings, LLC 286.17K Mar 31, 2026 0.71% $0.03 145.55%
Ranger Investment Management LP 278.48K Mar 31, 2026 0.69% $1.11 -0.34%
Oberweis Asset Management Inc 277.10K Mar 31, 2026 0.68% $0.45 32.08%
Capricorn Fund Managers Ltd 267.05K Mar 31, 2026 0.66% $2.30 45.05%
Charles Schwab Investment Management Inc 264.26K Mar 31, 2026 0.65% $0.00 -1.63%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 iShares Core S&P Small-Cap ETF 1.27M 3.13% ▲ 0.02% Jun 30, 2026
2 Vanguard Total Stock Mkt Idx Inv 659.63K 1.63% ▲ 3.19% Jun 30, 2026
3 iShares Russell 2000 ETF 552.03K 1.36% ▲ 0.60% Jun 30, 2026
4 Fidelity Low-Priced Stock 471.81K 1.16% ▲ 42.64% Apr 30, 2026
5 Strategic Advisers Fidelity US TtlStk 391.44K 0.97% ▼ 30.97% May 31, 2026
6 Lord Abbett Value Opportunities I 346.94K 0.86% ▲ 34.16% May 31, 2026
7 Lord Abbett Smid-Cap Equity SMA 346.94K 0.86% ▲ 50.52% Jun 30, 2026
8 Oberweis Micro-Cap Growth 300.20K 0.74% ▲ 12.94% Jun 30, 2026
9 Fidelity Small Cap Growth 289.73K 0.71% ▲ 68.13% Apr 30, 2026
10 Oberweis Micro-Cap 265.80K 0.66% ▲ 29.79% Mar 31, 2026

Financial Highlights

Market Cap: $1.48B
EBITDA: $234.75M
P/E Ratio: $15.09
PEG Ratio: $1.68
Book Value: $8.92
Dividend/Share: $0.48
Dividend Yield: 1.36%
Earnings/Share: $2.41
Profit Margin: 6.35%
Operating Margin: 12.56%
ROA (TTM): 8.40%
ROE (TTM): 30.34%
Revenue (TTM): $1.50B
Revenue/Share (TTM): $37.00
Earnings Growth (YOY): 15.70%
Revenue Growth (YOY): 10.30%

Valuation Metrics

Enterprise Value: $2.14B
Trailing P/E: 15.09
Forward P/E: 13.83

Shares Statistics

Shares Outstanding: 21.07M
Shares Float: 20.87M
% Insiders: 85.10%
% Institutions: 9,925.50%
Short % Float: 6.88%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$1.30B
Cost of Goods Sold
adjust
$-896.27M
Gross Profit
subtotal
$399.94M
SG&A
adjust
$-289.48M
R&D
adjust
$-23.73M
Operating Income
subtotal
$110.47M
Other / Non-Operating Items
adjust
$-62.20M
Net Income
subtotal
$48.26M

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about PAHC.US!